The recommended dosage of SKELAXIN in adults and pediatric patients 13 years of age and older is 800 mg orally three to four times a day [see Use in Specific Populations (8)].
SKELAXIN (metaxalone) tablets 800 mg are not substitutable on a mg to mg basis with Metaxalone Tablets, 640 mg [see Clinical Pharmacology (12.3)]. When it is appropriate to switch:
Do not switch from Metaxalone Tablets, 640 mg to SKELAXIN when the patient is taking food during administration.
The recommended dosage of SKELAXIN in adults and pediatric patients 13 years of age and older is 800 mg orally three to four times a day [see Use in Specific Populations (8)].
SKELAXIN (metaxalone) tablets 800 mg are not substitutable on a mg to mg basis with Metaxalone Tablets, 640 mg [see Clinical Pharmacology (12.3)]. When it is appropriate to switch:
Do not switch from Metaxalone Tablets, 640 mg to SKELAXIN when the patient is taking food during administration.
{{section_body_html_patient}}
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.